VEGFC and esophageal squamous cell carcinoma: Building upon this multidimensional understanding of ESCC metastasis, we hypothesized that an integrated biomarker signature (IBS) combining serum CA72-4, VEGF-C, and PGI/PGII ratio could overcome the limitations of current staging and single-marker approaches.